[Retracted] Analysis of the Application Value of Ultrasound Three-Dimensional Speckle Tracking Technology Combined with Thyroid Autoantibodies and Hormones in the Diagnosis and Treatment of Graves’ Disease

Figure 1

Comparison of thyroid autoantibody levels of study subjects ( ± s, %). The abscissa from left to right is the control group, the experimental group before treatment, and the experimental group after treatment, respectively. ^#. (a) TRAb level. The TRAb level of the experimental group before and after treatment was significantly higher than that of the control group (37.21 ± 5.22 vs. 11.98 ± 1.22, 25.15 ± 2.41 vs. 11.98 ± 1.22, ); the level of TRAb in the experimental group before treatment was significantly higher than after treatment (37.21 ± 5.22 vs. 25.15 ± 2.41, ). (b) TPOAb level (%). The TPOAb level of the experimental group before and after treatment was significantly higher than that of the control group (69.65 ± 5.14 vs. 26.54 ± 3.21, 45.26 ± 3.54 vs. 26.54 ± 3.21, ); the level of TPOAb was significantly higher than after treatment (69.65 ± 5.14 vs. 45.26 ± 3.54, ). (c) TGAb level (%). The TGAb level of the experimental group before and after treatment was significantly higher than that of the control group (28.98 ± 20.11 vs. 5.10 ± 4.98, 13.68 ± 10.14 vs. 5.10 ± 4.98, ); the level of TGAb was significantly higher than after treatment (28.98 ± 20.11 vs. 13.68 ± 10.14, ).

(a)

(b)

(c)